ArticleJournal of cellular and molecular medicine2021

Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress.

Yang Tai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.